Maternal and Infant Pregnancy Outcomes in Women with Psoriatic Arthritis: A Swedish Nationwide Cohort Study


Studies on pregnancy outcomes in psoriatic arthritis (PsA) are scarce and typically of small size. Available studies have reported conflicting results. The aim of this study was to describe maternal and infant pregnancy outcomes among women with PsA compared to women without PsA.


Nationwide cohort study.


Nationwide Swedish registers.


41485 singleton pregnancies in 1997-2014 where 541 pregnancies were identified with PsA exposure and 40 944 pregnancies were unexposed.


By linkage of national health and population register data we obtained information on individual pregnancies and compared outcomes among pregnancies with PsA to non-PsA pregnancies. Relative risks were estimated by odds ratios (ORs) with 95% CIs using a generalised linear regression model with GEE. Adjustments were made for maternal factors and calendar year of birth.


Maternal and infant pregnancy outcomes.


Pregnancies to women with PsA had increased risks of preterm birth: aOR 1.63; 95% CI 1.17-2.28, elective and emergency caesarean deliveries aOR: 1.47; 95% CI 1.10-1.97 and aOR 1.43; 95%CI 1.08-1.88, respectively, compared to non-PsA pregnancies. No increased risks were observed for pre-eclampsia, stillbirth or other infant outcomes apart from preterm birth.


The majority of women with PsA have uneventful pregnancies with respect to adverse outcomes. In the present study we found increased risks of preterm birth and caesarean delivery compared to non-PsA pregnancies.